During CannaBusiness Summit 2021, you will learn from the industry’s top leaders how to launch your cannabis company in Brazil according to the country’s latest regulations.
The online event will take place on February 9 and 10, 2021
According to Viviane Sedola, CEO of the Dr. Cannabis platform, specialist in consulting and the female cannabis leadership in Brazil “the domestic market makes room for the generation of USD 2.5 billion in the economy”*.
The growth expectation of the cannabis market is so great that it has earned the name green rush, in reference to the gold rush**.
The CannaBusiness Summit 2021 will feature speakers of national and international prestige who will clarify points such as: economy, local legislation, local regulation and opportunities in the Brazilian cannabis market.
The Cannabusiness Summit Brasil is an event aimed at entrepreneurs, investors and professionals who already work or wish to work in the legal cannabis market in Brazil.
A unique opportunity to learn from the main industry leaders in Brazil and the world.
Alex is a Digital Entrepreneur in series, he was a partner and founder of EduWeb and Affero Lab, the largest Corporate Education company in Brazil.
Until 2014 he held the position of Director for Latin America at the Canadian multinational Desire2Learn (D2L) and lived for more than 12 years in North America throughout his life.
Lucena founded in 2015 the company that participates in Startups 4H Tecnologia em Saúde, linked to the renowned Software Engineering Laboratory (LES) of PUC-Rio and angel investor of TRIA.health.
Eduardo Schenberg, PhD, followed a solid academic trajectory at the interface between psychology, psychiatry and neurosciences.
He graduated in biomedicine and did a master’s degree in psychopharmacology at UNIFESP and concluded a PhD in neurosciences at USP.
He specialized in the subject of psychoactive drugs and their most varied effects focusing on psychedelic substances (ayahuasca, LSD, ibogaine, MDMA and psilocybin, among others).
Rachel holds a law degree from PUC-SP; Master in Constitutional Law at PUC-SP; PhD in Constitutional Law from PUC-SP; Specialist in Notarial and Registry Law from Escola Paulista da Magistratura (EPM). She is also President of the Special Commission on Notarial Law and Public Registries at OAB-SP and Specialist in Notarial and Registry Law.
Tarso Araujo is a journalist, documentary filmmaker and consultant, specialist in health and drug policies. Writing articles on the topic, he has won the Abril Journalism, Esso Journalism and Gilberto Velho Media and Drugs Awards.
He is the author of the books Almanaque das Drogas-an Informal Guide to Rational Debate, (Leya, 2012) and Guide on Drugs for Journalists (Catalize, 2017).
In 2014, he created the Repense campaign, to raise awareness about the medical use of cannabis, and directed a series of shorts on the same theme, in addition to the feature film Illegal, about a group of mothers struggling to treat their children’s epilepsy with plant.
Tom Zuber is founder and managing partner of Zuber Lawler and also the founder of the international cannabis consultancy company Global Go. Tom is the relationship partner for about 10 Fortune 500 customers, as well as government funds and entities.
He earned a JD degree from Columbia Law School, a master’s degree in public policy from Harvard University and a biomedical engineering degree from Rutgers University, where he graduated with the highest degrees. honors.
Vinicius Alvarenga is a founding partner of Sinapse Social. Business administrator with relevant experience in the formation of multidisciplinary teams and business development. He served as CFO and COO in companies such as Construtora Tenda / Gafisa, Agua de Cheiro, Vivara Joias.
Amanda Zani has a degree in Chemistry from Faculdade São Bernardo do Campo and a specialization in Business Management from Fundação Getúlio Vargas.
He has worked in the field of technical consultative sales for the laboratory for over 15 years, and for the past eleven as an international sales manager for the German companies Huber and Memmert, both specialized in thermodynamics and temperature control for laboratory applications, pilot plant and production in various industrial and academic segments.
Paul Rosen is among a handful of seminal pioneers in the legalized global cannabis industry and one of his most active entrepreneurs, advisers and investors.
Paul Rosen was a co-founder of PharmaCan Capital Corp (NASDAQ: CRON; TSX: CRON) and served as its first CEO and president for four years.
Under Paul’s leadership, the PharmaCan / Cronos Group acquired stakes in several of the initial cannabis licenses granted in Canada and was the 3rd cannabis company to go public in Canada.
Dr Mario Luiz Grieco | CRM 32183 is a doctor graduated from the School of Medicine of São Paulo, specializing in Internal Medicine, occupational medicine, longevity and cannabinoid medicine.
Former President of Bristol-Myers Squibb (Brazil), Pfizer (USA), Pharmacia and UpJohn (USA) and Monsanto (Brazil).
He works with clinical research at USP and the University of Florida (USA). He has several works published in national and international magazines.
Carla Pareja Paris focuses on corporate transactions and regulatory issues, generally in relation to Europe and Latin America.
She has represented cannabis companies for most of her legal career. After graduating from a major university in Spain, she received her LL.M from the USC Law School. She works in Portuguese and Spanish.
Emilio Figueiredo has been a lawyer since 2004 and has worked in law and cannabis in Brazil for 10 years. He is on the executive board of Rede Reforma.
With a law degree from PUC-RIO (2003); postgraduate degree from the UFRJ Institute of Economics (2013); was a student in the “Drug Policy Reform” program at the Transnational Institute in Amsterdam (2014); graduated in Political Innovation from Academia Innovación Politica (2017) and is currently a master’s student in the Postgraduate Program in Justice and Security (PPGJS) of the Federal Fluminense University (UFF) as part of from the PsicoCult research group with an investigation into the participation of lawyers in producing the legal truth about Cannabis in Brazi
Andres is President and COO at Clever Leaves. Prior to Clever Leaves, Andres was a Founding Partner of Mojo Ventures. Before being an entrepreneur, Andres was President/CEO at IQ Outsourcing, a leading Colombian Business Process Outsourcing Firm that is part of the Sanford Group of Companies. Andres obtained an MBA at HARVARD BUSINESS SCHOOL. He is B.S. Industrial Engineering and B.S. Economics from Los Andes University in Colombia of which he graduated with honors (top 3% of the class).
Louis is the MD at Greenfield Global Opportunities Funda, a private equity fund based in Canada that invests in cannabis companies globally.
He is partnered in the Fund with leading Brazilian businessmen. As both a consultant and investor, Louis has worked across the medical cannabis sector, with companies in North America, South America, Europe and Asia.
His professional background is in health care policy and research, and he has held executive positions in multiple Canadian organizations.
Stephen is Co-Founder and Managing Director of Prohibition Partners, the leading source of intelligence and insights into the European cannabis industry and Co-Founder of Cannabis Europa, Europe’s premier medical cannabis conference.
Stephen is also Co-Founder & Director of Prohibition Holdings, a global leader in cannabis data, events and media, managing a portfolio of some of the best-known brands in the industry.
With a background in technology, digital media and corporate finance, Stephen works with investors, entrepreneurs and regulators to identify, qualify and maximise the opportunities in this emerging frontier.
Hector joins Prohibition Partners from PP’s newly opened São Paulo office, where he has been researching the Latin American and Caribbean (LAC) cannabis and hemp industries since June 2020. He graduated from International Affairs in Venezuela, and lived in Portugal and Spain, where he researched the LATAM startup and PEVC market.
Besides covering the LAC region at PP he is working as an instructor for the educational project Global Citizen Academy, while studying a Sustainability and Environmental master degree at Brazilian think-tank FVG.
Nilton Aquino is a pharmacist with specialization in pharmaceuticals and medications, an MBA in industrial management, a master’s and a doctorate in medical pathophysiology, in the area of developing new drugs for obesity and diabetes.
He served as technical manager, quality manager and research and development in pharmaceutical multinationals. In 2010 he founded ANS Pharma, a company specializing in advising and consulting in the areas of pharmaceutical technology and healthcare products (B2B).
In 2019 he founded QuantiFarma, focusing on pharmaceutical retail (B2C). He has experience in cutting-edge pharmaceutical research, including clinical and preclinical tests, physical-chemical tests and regulatory aspects necessary for the registration of new products in the world, including products in the field of medical cannabis.
10am BRT / 8am EST
Current scenario and perspectives
11am BRT / 9am EST
Current legislation and where we are going to
Congressman Paulo Teixeira and Rachel Ximenes
12am BRT/ 10am EST
Registering a cannabis product according to RDC 325/2019 and the raw material market
2pm BRT/12am EST
Quality Control and Laboratory Workflow in Brazil
Bruna Cassanho | Merck
3pm BRT / 1pm EST
Stability testing for Brazil (zone IV B)
4pm BRT / 2pm EST
The Pharmaceutical Market in Brazil
5pm BRT / 3pm EST
Drugstores, retail and distribution operations in Brazil
Leandro Luizi | Panorama Farmacêutico
6pm BRT / 4pm EST
Ancillary businesses opportunities in Brazil
Alex Lucena | The Green Hub
7pm BRT / 5pm EST
Alfredo Pascual and Viviane Sedola
10am BRT / 8 am EST
Extra: cannabis basics for market beginners
11am BRT / 9am EST
Extra: psychedelics use and regulatory framework in Brazil
2pm BRT / 12am EST
Extra: Legal affairs stablishing a cannabis company in Brazil
Vinicius Alvarenga and Emilio Figueiredo
3pm BRT / 1pm EST
Extra: Other cannabis based products
Tom Zuber, Paul Rosen, Carla Pareja and Andres Fajardo
4pm BRT / 2pm EST
Prescribing Doctor and Medicinal Cannabis
Dr. Mario Grieco
5pm BRT / 3am EST
Extra: harmonizing regulatory framework Brazil X Europe
Louis Barré, Stephen Murphy and Hector Gomes | Prohibition Partners
The event works in a 100% online format. You can watch from anywhere, just a computer, tablet or smartphone with internet access. On the day of the event we will send the link of the lecture transmission room to the email used in the registration, so you can participate!
Important tip: Cannabis content can be directed to your email’s SPAM box. Remeber to check and mark it as “It’s not SPAM”.
Yes, the lectures take place according to the schedule and are available for free access until the beginning of the next day. Therefore, you will have time not to miss anything! Cannabusiness Summit Brazil also offers a Premium Access where lectures and other content will be available for 6 months, so you can see and review as many times as you want in this period! This option is paid.
After purchase, Premium Access will be available within 2 business days after the end of the event. All details will be sent by email and access will be available for 6 months from the date the event ends.
Important tip: Cannabis content can be directed to your email’s SPAM box. Remember to check and mark it as “It’s not SPAM”.
Cannabusiness Summit Brazil is 100% free for your online participation when lectures are shown. Just complete your registration to participate and watch the entire content of the event, free of charge. The lectures will be available for access until the start of the next day’s program.
Dr. Cannabis | Copyright © 2020 All rights reserved